FMP

FMP

Enter

CO - Global Cord Blood Co...

photo-url-https://images.financialmodelingprep.com/symbol/CO.png

Global Cord Blood Corporation

CO

NYSE

Inactive Equity

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

2.99 USD

0 (0%)

Operating Data

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

5.16M

6.28M

7.17M

8.76M

8.83M

10.12M

11.61M

13.32M

15.28M

17.53M

Revenue %

-

21.69

14.24

22.1

0.79

14.7

14.7

14.7

14.7

Ebitda

-14.06M

-34.36M

-49.03M

-80.83M

-77.22M

-10.12M

-11.61M

-13.32M

-15.28M

-17.53M

Ebitda %

-272.54

-547.19

-683.59

-922.96

-874.85

-100

-100

-100

-100

Ebit

-16.79M

-36.96M

-51.37M

-82.68M

-77.22M

-10.12M

-11.61M

-13.32M

-15.28M

-17.53M

Ebit %

-325.37

-588.63

-716.12

-944.03

-874.85

-100

-100

-100

-100

Depreciation

2.73M

2.6M

2.33M

1.84M

-

2.99M

3.43M

3.94M

4.52M

5.18M

Depreciation %

52.83

41.44

32.52

21.07

-

29.57

29.57

29.57

29.57

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

21.34M

9.48M

7.07M

41.31M

177.98M

10.09M

11.58M

13.28M

15.23M

17.47M

Total Cash %

413.47

151.03

98.49

471.65

2.02k

99.7

99.7

99.7

99.7

Receivables

16.18M

438k

815k

1.74M

1.42M

3.12M

3.58M

4.11M

4.71M

5.41M

Receivables %

313.66

6.98

11.36

19.84

16.09

30.85

30.85

30.85

30.85

Inventories

2.52M

2.11M

2.2M

2.08M

1.69M

3.16M

3.62M

4.16M

4.77M

5.47M

Inventories %

48.86

33.67

30.61

23.73

19.1

31.19

31.19

31.19

31.19

Payable

2.18M

2.11M

3.76M

1.47M

815k

3.12M

3.58M

4.1M

4.71M

5.4M

Payable %

42.17

33.59

52.36

16.73

9.23

30.82

30.82

30.82

30.82

Cap Ex

-789k

-2M

-498k

-630k

-2.11M

-1.72M

-1.98M

-2.27M

-2.6M

-2.98M

Cap Ex %

-15.29

-31.84

-6.94

-7.19

-23.86

-17.02

-17.02

-17.02

-17.02

Weighted Average Cost Of Capital

Price

11.18

Beta

Diluted Shares Outstanding

192.13M

Costof Debt

4.11

Tax Rate

After Tax Cost Of Debt

4.11

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

8.25M

Total Equity

2.15B

Total Capital

2.16B

Debt Weighting

0.38

Equity Weighting

99.62

Wacc

9.35

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

5.16M

6.28M

7.17M

8.76M

8.83M

10.12M

11.61M

13.32M

15.28M

17.53M

Ebitda

-14.06M

-34.36M

-49.03M

-80.83M

-77.22M

-10.12M

-11.61M

-13.32M

-15.28M

-17.53M

Ebit

-16.79M

-36.96M

-51.37M

-82.68M

-77.22M

-10.12M

-11.61M

-13.32M

-15.28M

-17.53M

Tax Rate

-

-

-

-

-

-

-

-

-

-

Ebiat

-30.57M

-39.92M

-38.84M

-82.68M

-77.22M

-9.63M

-11.05M

-12.67M

-14.53M

-16.67M

Depreciation

2.73M

2.6M

2.33M

1.84M

-

2.99M

3.43M

3.94M

4.52M

5.18M

Receivables

16.18M

438k

815k

1.74M

1.42M

3.12M

3.58M

4.11M

4.71M

5.41M

Inventories

2.52M

2.11M

2.2M

2.08M

1.69M

3.16M

3.62M

4.16M

4.77M

5.47M

Payable

2.18M

2.11M

3.76M

1.47M

815k

3.12M

3.58M

4.1M

4.71M

5.4M

Cap Ex

-789k

-2M

-498k

-630k

-2.11M

-1.72M

-1.98M

-2.27M

-2.6M

-2.98M

Ufcf

-45.17M

-23.23M

-35.82M

-84.56M

-79.27M

-9.23M

-10.05M

-11.53M

-13.23M

-15.17M

Wacc

9.35

9.35

9.35

9.35

9.35

Pv Ufcf

-8.44M

-8.41M

-8.82M

-9.25M

-9.7M

Sum Pv Ufcf

-44.63M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

9.35

Free Cash Flow T1

-15.48M

Terminal Value

-210.65M

Present Terminal Value

-134.75M

Intrinsic Value

Enterprise Value

-179.38M

Net Debt

-169.73M

Equity Value

-9.65M

Diluted Shares Outstanding

192.13M

Equity Value Per Share

-0.05

Projected DCF

-0.05022866 223.582%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep